clinical trial · NCT06562114
A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
Merry Life Biomedical Co., Ltd.·phase1·completed·n = 72
HealthyTML-6 GranulesPlacebo
brief summary
The purpose of this study is to evaluate the safety, tolerability, single-ascending dose (SAD), multiple-ascending dose (MAD), food effect, and pharmacokinetic (PK) Study of TML-6.
started
Jul 11, 2024
primary completion
Jul 18, 2025
completion
Aug 15, 2025
last updated
Oct 30, 2025
official title
A Phase 1, Safety, Tolerability, Single-ascending Dose, Multiple-ascending Dose, Food Effect, and Pharmacokinetic Study of TML-6 in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol